ArticleJACC. Case reports2026
Unveiling Arrhythmogenic Cardiomyopathy Masquerading as Myocarditis in a Professional Athlete.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundElite athletes undergoing cardiovascular screening may present with findings that necessitate further work-up based on consensus electrocardiographic criteria. These findings may reveal conditions that may affect their cardiovascular health and livelihood. CASE SUMMARY: We present the case of an asymptomatic elite American-style football player with lateral T-wave inversions, frequent premature ventricular contractions, mildly reduced ejection fraction, and progressive myocardial scarring on cardiac magnetic resonance imaging. Genetic testing revealed a pathogenic desmin (DES) variant associated with arrhythmogenic and dilated cardiomyopathy spectrum. DISCUSSION: After multidisciplinary evaluation and extensive shared decision-making, the athlete was initially withheld from play. Given the absence of a plakophilin-2 (PKP2) mutation, lack of sustained ventricular arrhythmias, and preserved functional capacity, and after extensive shared decision-making, the athlete returned to play with strict longitudinal surveillance. TAKE-HOME MESSAGE: This case highlights the complexity of integrating advanced imaging, genetics, and athlete values into return-to-play decisions, and the ethical challenges when medical uncertainty intersects with professional identity and livelihood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.